Brata, R.; Pascalau, A.V.; Fratila, O.; Paul, I.; Muresan, M.M.; Camarasan, A.; Ilias, T.
Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review. Healthcare 2024, 12, 2464.
https://doi.org/10.3390/healthcare12232464
AMA Style
Brata R, Pascalau AV, Fratila O, Paul I, Muresan MM, Camarasan A, Ilias T.
Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review. Healthcare. 2024; 12(23):2464.
https://doi.org/10.3390/healthcare12232464
Chicago/Turabian Style
Brata, Roxana, Andrei Vasile Pascalau, Ovidiu Fratila, Ioana Paul, Mihaela Mirela Muresan, Andreea Camarasan, and Tiberia Ilias.
2024. "Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review" Healthcare 12, no. 23: 2464.
https://doi.org/10.3390/healthcare12232464
APA Style
Brata, R., Pascalau, A. V., Fratila, O., Paul, I., Muresan, M. M., Camarasan, A., & Ilias, T.
(2024). Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review. Healthcare, 12(23), 2464.
https://doi.org/10.3390/healthcare12232464
